United States

ResearchDx completes expansion

Wednesday, July 24, 2013 09:15 AM

ResearchDx, a contract diagnostics organization (CDO), has announced its purchase of and relocation to a 30,000-square-foot facility in Irvine, Calif. The facility will support continued expansion of in vitro diagnostic (IVD) development services to the pharmaceutical, biotechnology, diagnostic development and clinical laboratory industries.

More... »

Clinical Research Advantage acquires late phase division of Comprehensive Clinical Development

Wednesday, July 24, 2013 08:29 AM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a wholly owned network of clinical trial sites, has expanded both its geographic and therapeutic reach by acquiring the late phase division of Comprehensive Clinical Development (CCD).

More... »

Bristol-Myers Squibb to create 579 jobs

Friday, July 19, 2013 02:40 PM

Bristol-Myers Squibb will open a North America capability center and create 579 life sciences jobs in Tampa, Fla. The 70,000-square-foot facility will open in January 2014 with approximately 250 employees. The company will add more than 325 additional jobs by 2017.

More... »

Biotech Investment Group launches Formex

Friday, July 19, 2013 02:39 PM

Biotech Investment Group (BiG) has completed the purchase of PharmaForm and has launched Formex, a small molecule formulation company for the pharmaceutical and biotechnology industry.

More... »

VIVUS, First Manhattan reach settlement agreement

Friday, July 19, 2013 02:21 PM

Mountain View-based pharma company Vivus and New York-based First Manhattan (FMC), an owner-managed and operated investment advisory firm and the owner of 9.9% of Vivus’ outstanding shares, said they have entered a settlement agreement regarding their proxy contest related to Vivus’ 2013 annual meeting.

More... »

VC investment in biotech sector soars in second quarter

Friday, July 19, 2013 02:18 PM

Venture capitalists invested $6.7 billion in 913 deals in the second quarter of 2013, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

More... »

Banner Health, Mayo Clinic receive grant to identify early Parkinson's patients

Friday, July 19, 2013 01:24 PM

Researchers from Mayo Clinic Arizona and Banner Sun Health Research Institute are working together on a diagnostic test to identify early Parkinson's disease in patients thanks to a $152,486 grant from The Michael J. Fox Foundation for Parkinson's Research. Currently, there is no accurate diagnostic test for early Parkinson's.

More... »

Anti-TNF infusion therapy approved for RA patients

Friday, July 19, 2013 01:20 PM

The FDA has approved Janssen Biotech’s Simponi Aria (golimumab) infusion for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) in combination with methotrexate. Simponi Aria, the only fully-human anti-tumor necrosis factor (TNF)-alpha infusible therapy, has been shown to improve signs, symptoms and physical function and inhibit the progression of structural damage.

More... »

Trevena granted composition of matter patent for TRV027

Thursday, July 18, 2013 11:05 AM

Trevena, a clinical stage pharmaceutical company in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, said the U.S. Patent and Trademark Office has granted Trevena a composition of matter patent covering its development product TRV027.

More... »

Frontage Laboratories makes two senior appointments

Thursday, July 18, 2013 10:30 AM

George Laskaris and Alma Villasin have joined Frontage Laboratories in senior positions. Laskaris has been named senior director, Frontage Biometrics Services, and Villasin, R.N., B.S.N., M.B.A., joins as director, clinical operations.

More... »